Related Experiment Video

Updated: Mar 11, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.6K

G-Protein-Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer

Laura Nogués1, Clara Reglero1, Verónica Rivas1

  • 1Departamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa," Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain.

Molecular Pharmacology
|November 30, 2016
PubMed

Insights

G-protein-coupled receptor kinase 2 (GRK2) acts as a cancer-associated factor, influencing cell proliferation, survival, and motility. Its altered levels promote tumor growth and angiogenesis, positioning GRK2 as a key oncomodifier in carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Cancer development involves sustained proliferation, resistance to cell death, and metastasis.
  • Signaling nodes can promote tumor properties by interacting with oncogenic pathways.
  • G-protein-coupled receptor kinase 2 (GRK2) is emerging as a significant signaling node in cancer.

Purpose of the Study:

  • To investigate the role of GRK2 in cancer development and progression.
  • To understand how GRK2 modulates fundamental cellular functions relevant to tumorigenesis.
  • To explore GRK2's potential as an oncomodifier in various cancer types.

Main Methods:

  • Analysis of GRK2 expression and function in tumoral contexts.
  • Investigating GRK2's interactions with cellular signaling pathways.
  • Assessing the impact of altered GRK2 levels on cancer hallmarks like proliferation and angiogenesis.

Main Results:

  • Altered GRK2 levels are associated with various tumor types.
  • GRK2 promotes breast tumorigenesis and triggers the angiogenic switch.
  • GRK2 modulates cell proliferation, survival, motility, metabolic homeostasis, and inflammation.

Conclusions:

  • GRK2 functions as an oncomodifier, influencing multiple hallmarks of cancer.
  • GRK2's role in carcinogenesis is cell-type specific.
  • GRK2 represents a potential therapeutic target for modulating cancer progression.

More Related Videos

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

2.9K
RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K